HighTower Advisors
TMDX icon

HighTower Advisors’s Transmedics TMDX Stock Holding History

HighTower Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400
Closed -$775 – 3977
2024
Q2 		$775 Sell
400
-600
-60% -$72K ﹤0.01% 3575
2024
Q1 		$988 Buy
+1,000
New +$82.4K ﹤0.01% 3520

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's TMDX Position: Q1 2026 in Review

HighTower Advisors reduced its Transmedics (TMDX) stake by 24% in Q1 2026, selling an estimated $507K and leaving 12,519 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

HighTower Advisors first reported a position in TMDX in Q1 2021 and has held it in 20 quarters since. The position peaked at $3.63M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • HighTower Advisors held 12,519 shares of Transmedics worth $1.24M as of Q1 2026.
  • HighTower Advisors sold 3,888 Transmedics shares in Q1 2026, an estimated $507K.
  • Transmedics made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2034 holding.
  • HighTower Advisors first reported a position in Transmedics in Q1 2021 and has held it in 20 quarters since.
  • HighTower Advisors's Transmedics position peaked at $3.63M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.